Endometrial serous carcinoma (ESC) is often viewed as a prototype for aggressive endometrial cancer, as the majority of ESCs, marked by p53 mutations and lacking POLE ultramutations, fall into the p53abn category. The gene discussed is POLE; the disease is endometrial cancer.